If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Shi-Jun Wen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles
Cells Chemical Compounds
Carbazoles Chemical Compounds
Alkynes Chemical Compounds
Derivatives Chemical Compounds
Neoplasms Medicine & Life Sciences
Glycolysis Medicine & Life Sciences
Copper Chemical Compounds
Fluorenes Chemical Compounds

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2013 2019

  • 912 Citations
  • 17 h-Index
  • 46 Article
  • 2 Review article
2 Citations (Scopus)

Copper-Catalyzed One-Pot Synthesis of Dibenzofurans, Xanthenes, and Xanthones from Cyclic Diphenyl Iodoniums

Zhu, D., Li, M., Wu, Z., Du, Y., Luo, B., Huang, P. & Wen, S-J., Jul 31 2019, In : European Journal of Organic Chemistry. 2019, 28, p. 4566-4571 6 p.

Research output: Contribution to journalArticle

Xanthenes
Xanthones
Oxygenation
oxygenation
Copper

Discovery of a novel rhein-SAHA hybrid as a multi-targeted anti-glioblastoma drug

Chen, J., Luo, B., Wen, S. & Pi, R., Jan 1 2019, (Accepted/In press) In : Investigational New Drugs.

Research output: Contribution to journalArticle

Glioblastoma
Pharmaceutical Preparations
Protein Kinases
Histone Deacetylases
Hydroxamic Acids

Heterocyclic iodoniums as versatile synthons to approach diversified polycyclic heteroarenes

Zhu, D., Wu, Z., Liang, L., Sun, Y., Luo, B., Huang, P. & Wen, S., Jan 1 2019, In : RSC Advances. 9, 57, p. 33170-33179 10 p.

Research output: Contribution to journalArticle

Open Access
Thiophenes
Thiophene
Scaffolds
Drug products
Pharmaceutical Preparations
1 Citation (Scopus)

Metabolic reprogramming and redox adaptation in sorafenib-resistant leukemia cells: Detected by untargeted metabolomics and stable isotope tracing analysis

You, X., Jiang, W., Lu, W., Zhang, H., Yu, T., Tian, J., Wen, S-J., Garcia-Manero, G., Huang, P. & Hu, Y-M., Apr 4 2019, In : Cancer Communications. 39, 1, 17.

Research output: Contribution to journalArticle

Open Access
Metabolomics
Isotopes
Protein-Tyrosine Kinases
Oxidation-Reduction
Leukemia

Synergy between auranofin and celecoxib against colon cancer in vitro and in vivo through a novel redox-mediated mechanism

Han, Y., Chen, P., Zhang, Y., Lu, W., Ding, W., Luo, Y., Wen, S-J., Xu, R-H., Liu, P. & Huang, P., Jul 1 2019, In : Cancers. 11, 7, 931.

Research output: Contribution to journalArticle

Open Access
Celecoxib
Auranofin
Colonic Neoplasms
Oxidation-Reduction
United States Food and Drug Administration